Ausgabe 2/2020
Inhalt (13 Artikel)
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects
Shivani Seth, Saurabh Zanwar, Linh Vu, Prashant Kapoor
Supportive Care in Multiple Myeloma
Amy Guzdar, Caitlin Costello
Extramedullary Disease in Multiple Myeloma
Megan H. Jagosky, Saad Z. Usmani
Is There a Role for Chemotherapy in the Era of Targeted Therapies?
Jason C. Lee, Nicole Lamanna
MLL-Rearranged Acute Lymphoblastic Leukemia
Firas El Chaer, Michael Keng, Karen K. Ballen
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
Morgan Hakki
Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia
HeeJin Cheon, Karolina H. Dziewulska, Katharine B. Moosic, Kristine C. Olson, Alejandro A. Gru, David J. Feith, Thomas P. Loughran Jr.
Advances and Perspectives in the Treatment of T-PLL
Till Braun, Jana von Jan, Linus Wahnschaffe, Marco Herling
Polatuzumab Vedotin: a New Target for B Cell Malignancies
Yun Choi, Catherine S. Diefenbach
The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy
Faizi A. Jamal, Samer K. Khaled
Novel Therapies in Polycythemia Vera
Douglas Tremblay, John Mascarenhas
Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults
Nicole Kucine
Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health Span
Shimoli V. Barot, Bhumika J. Patel, Aaron T. Gerds